Minjun Chen

5.6k total citations · 2 hit papers
104 papers, 4.0k citations indexed

About

Minjun Chen is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Minjun Chen has authored 104 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pharmacology, 30 papers in Molecular Biology and 26 papers in Epidemiology. Recurrent topics in Minjun Chen's work include Drug-Induced Hepatotoxicity and Protection (40 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Computational Drug Discovery Methods (24 papers). Minjun Chen is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (40 papers), Pharmacogenetics and Drug Metabolism (34 papers) and Computational Drug Discovery Methods (24 papers). Minjun Chen collaborates with scholars based in United States, China and Germany. Minjun Chen's co-authors include Weida Tong, Jürgen Borlak, Ayako Suzuki, Hong Fang, Huixiao Hong, Hui Wang, Shraddha Thakkar, M. Isabel Lucena, Raúl J. Andrade and Ke Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biomaterials.

In The Last Decade

Minjun Chen

98 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FDA-approved drug labeling for the study of drug-induced liver injury

2011 296 citations Minjun Chen, Vikrant Vijay et al. Drug Discovery Today profile →
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

2016 267 citations Minjun Chen, Weida Tong et al. Drug Discovery Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minjun Chen United States	35	1.5k	1.2k	893	624	441	104	4.0k
Lauren M. Aleksunes United States	48	1.4k 1.0×	2.8k 2.3×	374 0.4×	1.0k 1.6×	108 0.2×	168	7.0k
Manthena V. S. Varma United States	44	2.1k 1.4×	1.0k 0.9×	635 0.7×	402 0.6×	98 0.2×	127	5.7k
Taimour Langaee United States	37	2.5k 1.7×	1.5k 1.2×	313 0.4×	361 0.6×	192 0.4×	152	5.5k
Neil Parrott Switzerland	37	1.5k 1.0×	1.0k 0.9×	516 0.6×	266 0.4×	71 0.2×	125	4.5k
Xiaohe Xiao China	45	2.7k 1.8×	3.9k 3.2×	236 0.3×	903 1.4×	128 0.3×	396	8.6k
Thierry Lavé Switzerland	35	1.3k 0.9×	682 0.6×	485 0.5×	203 0.3×	56 0.1×	68	3.0k
Allen H. Heller United States	21	494 0.3×	582 0.5×	286 0.3×	269 0.4×	188 0.4×	48	2.5k
Richard D. Beger United States	40	773 0.5×	3.2k 2.6×	408 0.5×	495 0.8×	50 0.1×	163	5.8k
Eric Chun Yong Chan Singapore	41	854 0.6×	3.1k 2.5×	165 0.2×	297 0.5×	76 0.2×	186	5.5k
Xiao Ma China	40	1.0k 0.7×	2.3k 1.9×	97 0.1×	812 1.3×	223 0.5×	261	5.4k

Countries citing papers authored by Minjun Chen

Since Specialization

Citations

This map shows the geographic impact of Minjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjun Chen more than expected).

Fields of papers citing papers by Minjun Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjun Chen. The network helps show where Minjun Chen may publish in the future.

Co-authorship network of co-authors of Minjun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Minjun Chen. A scholar is included among the top collaborators of Minjun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minjun Chen. Minjun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Minjun, et al.. (2025). New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?. Drug Discovery Today. 30(9). 104452–104452. 2 indexed citations

Niu, Hao, Ismael Álvarez‐Álvarez, & Minjun Chen. (2025). Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury. Liver International. 45(3). e70038–e70038. 2 indexed citations

Chen, Minjun, L. Huang, Li Chen, et al.. (2025). Construction of a Palliative Care Services Framework for End‐of‐Life Adult Patients at Medical Institutions: A Delphi Study. European Journal of Cancer Care. 2025(1).

Patel, Tejas, et al.. (2024). Composite Plot for Visualizing Aminotransferase and Bilirubin Changes in Clinical Trials of Subjects with Abnormal Baseline Values. Drug Safety. 47(7). 699–710. 4 indexed citations

Zhao, Jinwen, et al.. (2024). Drug interaction with UDP-Glucuronosyltransferase (UGT) enzymes is a predictor of drug-induced liver injury. Hepatology. 81(5). 1512–1521. 5 indexed citations

Crosby, Lynn M., et al.. (2024). Medical device report analyses from MAUDE: Device and patient outcomes, adverse events, and sex-based differential effects. Regulatory Toxicology and Pharmacology. 149. 105591–105591. 2 indexed citations

Chen, Minjun, et al.. (2019). MicroRNA-138 negatively regulates the hypoxia-inducible factor 1α to suppress melanoma growth and metastasis. Biology Open. 8(8). 16 indexed citations

Chen, Minjun, et al.. (2019). The landscape of hepatobiliary adverse reactions across 53 herbal and dietary supplements reveals immune-mediated injury as a common cause of hepatitis. Archives of Toxicology. 94(1). 273–293. 13 indexed citations

Wu, Leihong, Zhichao Liu, Joshua Xu, et al.. (2015). NETBAGs: A Network-Based Clustering Approach with Gene Signatures for Cancer Subtyping Analysis. Biomarkers in Medicine. 9(11). 1053–1065. 7 indexed citations

10.

Hawser, Stephen, Samuel K. Bouchillon, Meredith Hackel, Minjun Chen, & Eui-Chong Kim. (2012). Trending 7 years of in vitro activity of tigecycline and comparators against Gram-positive and Gram-negative pathogens from the Asia-Pacific region: Tigecycline Evaluation Surveillance Trial (TEST) 2004–2010. International Journal of Antimicrobial Agents. 39(6). 490–495. 9 indexed citations

11.

Zhao, Chunjiang, Hongli Sun, Hui Wang, et al.. (2012). Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005–2010). Diagnostic Microbiology and Infectious Disease. 73(2). 174–181. 59 indexed citations

12.

Chen, Minjun, Vikrant Vijay, Qiang Shi, et al.. (2011). FDA-approved drug labeling for the study of drug-induced liver injury. Drug Discovery Today. 16(15-16). 697–703. 296 indexed citations breakdown →

13.

Yang, Qiwen, Hui Wang, Hongli Sun, et al.. (2009). Phenotypic and Genotypic Characterization of Enterobacteriaceae with Decreased Susceptibility to Carbapenems: Results from Large Hospital-Based Surveillance Studies in China. Antimicrobial Agents and Chemotherapy. 54(1). 573–577. 65 indexed citations

14.

Wang, Hui & Minjun Chen. (2009). The microbiology laboratory should intensively cooperate with the clinicians to improve the diagnostic level of pulmonary infections. Zhonghua jianyan yixue zazhi. 32(3). 245–248. 1 indexed citations

15.

Chen, Hongbin, et al.. (2009). The molecular characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus in China. Zhonghua jianyan yixue zazhi. 32(11). 1223–1227. 2 indexed citations

16.

Chen, Minjun. (2009). Antimicrobial Resistance Surveillance on Hospital-and Community-acquired Pathogens in 10 Teaching Hospitals in China. Zhongguo yiyuan ganranxue zazhi. 1 indexed citations

17.

Qiu, Yunping, Minjun Chen, Guoxiang Xie, et al.. (2008). Metabolic profiling reveals therapeutic effects of Herba Cistanches in an animal model of hydrocortisone-induced 'kidney-deficiency syndrome'. Chinese Medicine. 3(1). 3–3. 29 indexed citations

18.

Schnackenberg, Laura K., Minjun Chen, Jinchun Sun, et al.. (2008). Evaluations of the trans-sulfuration pathway in multiple liver toxicity studies. Toxicology and Applied Pharmacology. 235(1). 25–32. 28 indexed citations

19.

Ni, Yan, Mingming Su, Yunping Qiu, et al.. (2007). Metabolic profiling using combined GC–MS and LC–MS provides a systems understanding of aristolochic acid‐induced nephrotoxicity in rat. FEBS Letters. 581(4). 707–711. 92 indexed citations

20.

Chen, Minjun. (2002). Resistance mechanism of erythromycin in Streptococcus pneumoniae. Zhonghua jianyan yixue zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact